Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Subcutaneous interferon β-1a in pediatric patients with multiple sclerosis: Regional differences in clinical features, disease management, and treatment outcomes in an international retrospective study.
Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis.
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice.
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.
Intractable Nausea and Vomiting from Autoantibodies Against a Brain Water Channel.
A cross-sectional study examining multiple mobility device use and fall status among middle-aged and older adults with multiple sclerosis.
The histaminergic network in the brain: basic organization and role in disease.
The geometric and spatial constraints of the microenvironment induce oligodendrocyte differentiation.
Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave Dreams Study (Brain Venous Drainage Exploited Against Multiple Sclerosis): study protocol for a randomized controlled trial.
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (DreaMS)
Is multiple sclerosis a proresolution deficiency disorder?
Targeting human oligodendrocyte progenitors for myelin repair.
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.
Multiple Sclerosis: Myeloperoxidase Immunoradiology Improves Detection of Acute and Chronic Disease in Experimental Model.
Severe disease reactivation in four patients with relapsing-remitting multiple sclerosis after fingolimod cessation.
Tremor reduction and quality of life after deep brain stimulation for multiple sclerosis-associated tremor.
Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod.
Tumor-like multiple sclerosis.
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
[Posture disorders in patients with multiple sclerosis.]
Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
JC viremia in natalizumab-treated patients with multiple sclerosis.
Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Randomized Clinical Trials.
DYNACIN (MINOCYCLINE)
The prospects of minocycline in multiple sclerosis.
Pages
« first
‹ previous
…
182
183
184
185
186
187
188
189
190
…
next ›
last »